Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells
Article in Expert Review of Vaccines (September 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Article in Expert Review of Vaccines (September 2024)
Preprint in Preprints.org (August 2024)
Article in Hematology/Oncology Clinics of North America (July 2024)